Natural Product (NP) Details
| General Information of the NP (ID: NP3553) | |||||
|---|---|---|---|---|---|
| Name |
Serotonin
|
||||
| Synonyms |
serotonin; 5-HYDROXYTRYPTAMINE; 3-(2-Aminoethyl)-1H-indol-5-ol; 50-67-9; Enteramine; 5-HT; Thrombocytin; Thrombotonin; Antemovis; Serotonine; Ds substance; 1H-Indol-5-ol, 3-(2-aminoethyl)-; Hippophain; Antemoqua; Substance DS; Substanz DS; 3-(2-Aminoethyl)indol-5-ol; 5-Hta; Tryptamine, 5-hydroxy-; Indol-5-ol, 3-(2-aminoethyl)-; Enteramin; UNII-333DO1RDJY; 3-(beta-Aminoethyl)-5-hydroxyindole; 5-Hydroxy-3-(beta-aminoethyl)indole; 3-(2-Amino-ethyl)-1H-indol-5-ol; 333DO1RDJY; CHEBI:28790; Hippophaine; [3H]-5-HT; EINECS 200-058-9; BRN 0143524; 5-hydroxytryptamin; 5-Hydroxytriptamine; 5-Hydroxyltryptamine; 5-hydroxy-tryptamine; 1H-Indol-5-ol,3-(2-aminoethyl)-; 5-hydroxyl tryptamine; GTPL5; CHEMBL39; Prestwick0_000481; Prestwick1_000481; Prestwick2_000481; Prestwick3_000481; Lopac-H-9523; Biomol-NT_000083; bmse000757; SCHEMBL1495; Lopac0_000607; Oprea1_712368; BSPBio_000341; BSPBio_001112; KBioGR_000452; KBioGR_002472; KBioSS_000452; KBioSS_002479; 5-22-12-00016 (Beilstein Handbook Reference); Serotonin, analytical standard; SPBio_002262; 5-Hydroxytryptamine, free base; BPBio1_000377; BPBio1_001079; DTXSID8075330; BCBcMAP01_000198; BDBM10755; KBio2_000452; KBio2_002472; KBio2_003020; KBio2_005040; KBio2_005588; KBio2_007608; KBio3_000843; KBio3_000844; KBio3_002950; ZINC57058; cMAP_000059; 3-(b-Aminoethyl)-5-hydroxyindole; 5-Hydroxy-3-(b-aminoethyl)indole; Bio1_000450; Bio1_000939; Bio1_001428; Bio2_000396; Bio2_000876; HMS1362H13; HMS1792H13; HMS1990H13; HMS3403H13; 3-(2-Aminoethyl)-1H-indol-5-o; ALBB-006183; 6996AB; MFCD00055054; PDSP1_001512; PDSP2_001496; STK503758; AKOS001484724; 3-(2-Aminoethyl)-1H-indol-5-ol #; CCG-204696; DB08839; MCULE-8788459983; SDCCGSBI-0050589.P002; 3-(.beta.-Aminoethyl)-5-hydroxyindole; 5-Hydroxy-3-(.beta.-aminoethyl)indole; IDI1_002151; SMP1_000272; 5-hydroxy tryptamine creatinine disulfate; NCGC00015525-01; NCGC00015525-02; NCGC00015525-03; NCGC00015525-04; NCGC00015525-05; NCGC00015525-06; NCGC00015525-07; NCGC00015525-08; NCGC00015525-09; NCGC00015525-19; NCGC00142449-01; NCGC00142449-02; NCGC00142449-03; NCGC00142449-04; NCGC00142449-05; CAS-153-98-0; DB-051820; FT-0631212; 14C-5-hydroxy tryptamine creatinine disulfate; C00780; H-8000; K-9367; L000078; Q167934; 6F7FD5B4-A558-45F0-A20A-2D068A3EFE6A; 2-imino-1-methylimidazolidin-4-one; 3-(2-aminoethyl)-1H-indol-5-ol; bis(sulfuric acid); 1094000-36-8
Click to Show/Hide
|
||||
| Species Origin | Mucuna pruriens ... | Click to Show/Hide | |||
| Mucuna pruriens | |||||
| Disease | Depression [ICD-11: 6A70-6A71] | Investigative | [1] | ||
| Structure |
|
Click to Download Mol2D MOL |
|||
| ADMET Property |
Absporption
Caco-2 Permeability
-4.853
MDCK Permeability
-5.007
PAMPA
+
HIA
- - -
Distribution
VDss
0.65
PPB
38.2%
BBB
+
Metabolism
CYP1A2 inhibitor
+++
CYP1A2 substrate
+++
CYP2C19 inhibitor
- - -
CYP2C19 substrate
+
CYP2C9 inhibitor
- - -
CYP2C9 substrate
+++
CYP2D6 inhibitor
- - -
CYP2D6 substrate
+++
CYP3A4 inhibitor
- - -
CYP3A4 substrate
- - -
CYP2B6 inhibitor
- - -
CYP2B6 substrate
+++
CYP2C8 inhibitor
- - -
HLM Stability
- - -
Excretion
CLplasma
10.426
T1/2
1.3
Toxicity
DILI
- - -
Rat Oral Acute Toxicity
+
FDAMDD
++
Respiratory
++
Human Hepatotoxicity
+
Ototoxicity
-
Drug-induced Nephrotoxicity
- -
Drug-induced Neurotoxicity
++
Hematotoxicity
- -
Genotoxicity
+
Tips: 1. For the classification endpoints, the prediction probability values are transformed into six symbols: 0-0.1 (- - -), 0.1-0.3 (- -), 0.3-0.5 (-), 0.5-0.7 (+), 0.7-0.9 (++), and 0.9-1.0 (+++).
2. Additionally, the corresponding relationships of the three labels are as follows: excellent; medium; poor.
Click to Show/Hide
|
||||
| Click to Show/Hide the Molecular Information and External Link(s) of This Natural Product | |||||
| Formula |
C10H12N2O
|
||||
| PubChem CID | |||||
| Canonical SMILES |
C1=CC2=C(C=C1O)C(=CN2)CCN
|
||||
| InChI |
1S/C10H12N2O/c11-4-3-7-6-12-10-2-1-8(13)5-9(7)10/h1-2,5-6,12-13H,3-4,11H2
|
||||
| InChIKey |
QZAYGJVTTNCVMB-UHFFFAOYSA-N
|
||||
| CAS Number |
CAS 50-67-9
|
||||
| ChEBI ID | |||||
| Herb ID | |||||
| SymMap ID | |||||
| TCMSP ID | |||||
| TTD Drug ID | |||||
| Combinatorial Therapeutic Effect(s) Validated Clinically or Experimentally | ||||||
|---|---|---|---|---|---|---|
| α. A List of Drug(s) Whose Efficacy can be Enhanced by This NP | ||||||
| Lidocaine | Corneal disease | Click to Show/Hide the Molecular Data of This Drug | ||||
| Achieving Therapeutic Synergy | Click to Show/Hide | |||||
| Representative Experiment Reporting the Effect of This Combination | [2] | |||||
| Detail(s) |
Combination Info
click to show the detail info of this combination
|
|||||
| In-vivo Model | Male adult Sprague-Dawley rats, weighing 201 to 251 g were used in this study. | |||||
| Experimental
Result(s) |
Serotonin and dopamine produce dose-related cutaneous analgesic effects as an infiltrative anesthetic. | |||||
| Target and Pathway | ||||
|---|---|---|---|---|
| Target(s) | Adenosine A3 receptor (ADORA3) | Molecule Info | [3] | |
| Serotonin receptor (5HTR) | Molecule Info | [4] | ||
| Reactome | Adenosine P1 receptors | Click to Show/Hide | ||
| 2 | G alpha (i) signalling events | |||
| WikiPathways | Nucleotide GPCRs | Click to Show/Hide | ||
| 2 | GPCRs, Class A Rhodopsin-like | |||
| 3 | GPCRs, Other | |||